Monitoring the hepatobiliary function using image techniques and labeled cholephilic compounds
-
Published:2023-02-28
Issue:
Volume:
Page:18-33
-
ISSN:
-
Container-title:Exploration of Digestive Diseases
-
language:en
-
Short-container-title:Explor Dig Dis
Author:
de Blas Beatriz Sanchez1ORCID, Temprano Alvaro G.2ORCID, Marin Jose J. G.2ORCID, Romero Marta R.2ORCID
Affiliation:
1. Experimental Hepatology and Drug Targeting (HEVEPHARM), University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain 2. Experimental Hepatology and Drug Targeting (HEVEPHARM), University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain
Abstract
Evaluation of the hepatobiliary function is critical for the clinicians, not only for the diagnosis of a large variety of liver diseases but also in the follow-up and management of some patients, for instance, those with different degrees of cholestasis suffering from a drug-induced liver injury (DILI) or scheduled for liver resection. Currently, the determination of global liver function mainly relies on laboratory tests, clinical scores, and data from images obtained with ultrasonography, computed tomography (CT), or magnetic resonance. Nuclear medicine scanning, displaying either planar or three-dimensional spatial distribution of liver function, is enhanced when using hepatotropic tracers based on classical radioisotopes such as technetium-99m (99mTc) and with higher resolution using metabolized probes such as those based on monosaccharide derivatives labeled with 18F. Other cholephilic compounds, and hence selectively secreted into bile, have been proposed to visualize the correct function of the liver parenchyma and the associated secretory machinery. This review aims to summarize the state-of-the-art regarding the techniques and chemical probes available to monitor liver and gallbladder function, in some cases based on imaging techniques reflecting the dynamic of labeled cholephilic compounds.
Funder
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Consejería de Educación, Junta de Castilla y León Fundación Científica Asociación Española Contra el Cáncer
Publisher
Open Exploration Publishing
Subject
General Medicine,Psychiatry and Mental health,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine,Family Practice,Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,General Medicine,General Medicine,Care Planning,Public Health, Environmental and Occupational Health,Animal Science and Zoology,Nature and Landscape Conservation,Animal Science and Zoology,Ecology, Evolution, Behavior and Systematics
Reference114 articles.
1. Masoodi M, Gastaldelli A, Hyötyläinen T, Arretxe E, Alonso C, Gaggini M, et al. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nat Rev Gastroenterol Hepatol. 2021;18:835–56. 2. Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S. Abnormal liver enzymes: a review for clinicians. World J Hepatol. 2021;13:1688–98. 3. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9. 4. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PCJ. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–71. 5. Tulchinsky M, Colletti PM, Allen TW. Hepatobiliary scintigraphy in acute cholecystitis. Semin Nucl Med. 2012;42:84–100.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|